Covid-19 Innovation Challenges by Innoget

SARS-CoV-2 Targeted Libraries for offer

Posted by Covid-19 Innovation Challenges by InnogetVery responsive · Innovative Products and Technologies · United Kingdom

Summary of the technology

Protease-Oriented SARS-CoV-2 Library (1017 Compounds) - Developed by Virtual Receptor-Based Screening Using the Crystal Structure of the Basic SARS-CoV-2 Protease (PDB ID: 6LU7)
ML (Machine Learning) SARS-target library (1577 compounds) - carefully developed using machine learning (artificial neural networks and Bayesian statistics).

Covid-19 Innovation Challenges by Innoget

Description of the technology

The Otava Research Institute cannot ignore today's challenges and presents targeted SARS-CoV-2 libraries that contain small compounds with putative SARS-CoV-2 activity http://bit.ly/38Y1TEI. We hope that these libraries will be useful for the study and development of drugs against # COVID19.

Protease-Oriented SARS-CoV-2 Library (1017 Compounds) - Developed by Virtual Receptor-Based Screening Using the Crystal Structure of the Basic SARS-CoV-2 Protease (PDB ID: 6LU7)
ML (Machine Learning) SARS-target library (1577 compounds) - carefully developed using machine learning (artificial neural networks and Bayesian statistics).

All warehouses are in stock, delivery is possible.

Be healthy and take care of yourself!

Technology Owner

Covid-19 Innovation Challenges by Innoget

Innovation Intermediary

Related keywords

  • Biological Sciences
  • Medicine, Human Health
  • Biostatistics, Epidemiology
  • Virus, Virology / Antibiotics / Bacteriology
  • Human vaccines
  • Emergency Medicine Technology
  • Infectious Diseases
  • Medical/health
  • Medical Health related
  • Other Medical/Health Related
  • Emergency medicine Market
  • Covid-19
  • compounds
  • sars-cov-2
  • compounds library
  • libraries

About Covid-19 Innovation Challenges by Innoget

Innovation Intermediary from United Kingdom

Ahead of the current Coronavirus outbreak, Innoget is fully committed to contributing to mobilizing scientific and expert communities to find a real solution to the Covid-19 pandemic. Therefore, we're supporting worldwide calls and programs that could help in any aspects of the coronavirus crisis.

Is your organization promoting or looking for innovation or research initiatives to mitigate the Covid-19 outbreak? Email us at covid19@innoget.com to list them.

Channeled through Innoget's online open innovation network, initiatives in the health, virology, medicine, or novel technologies applied to human health, among others, are listed and disseminated to Innoget members -ranging from hospitals, research institutes, scientists, businesses, and public administrations- and innovation partners worldwide.